Ultragenyx Pharmaceutical (RARE) Insider Trading & Ownership

$43.20
-1.08 (-2.44%)
(As of 02:46 PM ET)

Ultragenyx Pharmaceutical (NASDAQ:RARE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$5.33 M
Get RARE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RARE Insider Buying and Selling by Quarter

Ultragenyx Pharmaceutical Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/18/2024Eric CrombezEVPSell142$44.10$6,262.20  
3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37  
3/7/2024Matthew K FustDirectorSell12,195$50.88$620,481.60  
3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.48  
3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.56  
3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.16  
10/23/2023Thomas Richard KassbergEVPSell39,878$32.78$1,307,200.84  
10/19/2023Emil D KakkisCEOSell47,853$33.52$1,604,032.56  
9/7/2023Theodore Alan HuizengaCAOSell2,163$40.80$88,250.40  
9/5/2023Erik HarrisEVPSell6,000$37.96$227,760.00  
9/1/2023Theodore Alan HuizengaCAOSell970$37.15$36,035.50  
6/30/2023Corazon (Corsee) D SandersDirectorSell585$46.76$27,354.60  
6/19/2023Erik HarrisEVPSell305$48.20$14,701.00  
6/8/2023Corazon (Corsee) D SandersDirectorSell1,485$51.65$76,700.25  
5/18/2023John Richard PinionInsiderSell2,012$50.00$100,600.00  
5/4/2023Karah Herdman ParschauerEVPSell4,378$45.00$197,010.00  
(Data available from 1/1/2013 forward)

RARE Insider Trading Activity - Frequently Asked Questions

Who is on Ultragenyx Pharmaceutical's Insider Roster?
What percentage of Ultragenyx Pharmaceutical stock is owned by insiders?

6.80% of Ultragenyx Pharmaceutical stock is owned by insiders. Learn more on RARE's insider holdings.

Which Ultragenyx Pharmaceutical insiders have been selling company stock?

The following insiders have sold RARE shares in the last 24 months: Camille L Bedrosian ($175,615.25), Corazon (Corsee) D Sanders ($104,054.85), Dennis Karl Huang ($17,757.85), Emil D Kakkis ($1,604,032.56), Eric Crombez ($6,262.20), Erik Harris ($258,621.10), John Richard Pinion ($324,940.48), Karah Herdman Parschauer ($398,932.56), Mardi Dier ($198,579.12), Matthew K Fust ($620,481.60), Theodore Alan Huizenga ($259,633.42), and Thomas Richard Kassberg ($1,881,845.21).

How much insider selling is happening at Ultragenyx Pharmaceutical?

Insiders have sold a total of 150,093 Ultragenyx Pharmaceutical shares in the last 24 months for a total of $5,850,756.20 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:RARE) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners